Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Zeltiq Aesthetics Names Mark Foley President,CEO

RELATED NEWS
Trade ZLTQ now with 

Zeltiq aesthetics, Inc.(ZLTQ: Quote), a medical technology company, Friday said that it appointed Mark Foley as President and Chief Executive Officer with immediate effect. Mark has been serving as interim president and CEO since April and a member of the Board of Directors since 2009.

Foley has 25 years of experience in the medical device industry and served in senior operating roles with large cap companies and venture-backed start-ups.

Thursday, ZELTIQ closed at $5.04 on the Nasdaq.

Click here to receive FREE breaking news email alerts for ZELTIQ Aesthetics, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The European Central Bank left its key interest rates unchanged at a record low, after reducing them in a surprise move last month, as economic momentum in the euro area remains subdued. The Governing Council, led by President Mario Draghi, held the refinancing rate at a record low 0.05 percent following its policy meeting in Naples, Italy on Thursday. Hector Beltran Leyva, one of Mexico's most-wanted drug lords, was arrested on Wednesday. Mexican special forces captured Hector as he dined at a seafood restaurant in the city of San Miguel de Allende, a popular hub of foreigners and artists in the central state of Guanajuato. Federal criminal investigations chief Tomas Zeron told the media that no shots were fired in the operation, which culminat Stocks moved sharply lower over the course of the trading day on Wednesday, adding to the modest weakness seen in the two previous sessions. With the losses on the day, the major averages fell to their lowest closing levels in over a month.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.